A study of the PAN-KRAS inhibitor LY4066434 in participants with KRAS mutant solid tumors.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516733-12-00

Acronym

J5Q-OX-JRDA

Enrollment

353

Registered

2024-11-20

Start date

2025-05-13

Completion date

Unknown

Last updated

2025-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumor Metastatic Solid Tumor, Colorectal Cancer, Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, PanKRAS.

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026